Annual Non Current Assets
$2.09 B
-$292.82 M-12.26%
31 December 2023
Summary:
Amneal Pharmaceuticals annual long term assets is currently $2.09 billion, with the most recent change of -$292.82 million (-12.26%) on 31 December 2023. During the last 3 years, it has fallen by -$359.79 million (-14.66%). AMRX annual non current assets is now -31.68% below its all-time high of $3.07 billion, reached on 31 December 2018.AMRX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$1.95 B
-$76.76 M-3.79%
30 September 2024
Summary:
Amneal Pharmaceuticals quarterly long term assets is currently $1.95 billion, with the most recent change of -$76.76 million (-3.79%) on 30 September 2024. Over the past year, it has dropped by -$283.32 million (-12.70%). AMRX quarterly non current assets is now -39.07% below its all-time high of $3.20 billion, reached on 30 June 2018.AMRX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AMRX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | -12.7% |
| 3 y3 years | -14.7% | -19.0% |
| 5 y5 years | -31.7% | -22.0% |
AMRX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.7% | at low | -22.1% | at low |
| 5 y | 5 years | -31.7% | at low | -25.6% | at low |
| alltime | all time | -31.7% | +267.5% | -39.1% | +241.7% |
Amneal Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.95 B(-3.8%) |
| June 2024 | - | $2.02 B(-2.5%) |
| Mar 2024 | - | $2.08 B(-0.9%) |
| Dec 2023 | $1.38 B(-2.4%) | $2.09 B(-6.1%) |
| Sept 2023 | - | $2.23 B(-2.1%) |
| June 2023 | - | $2.28 B(-1.7%) |
| Mar 2023 | - | $2.32 B(-2.9%) |
| Dec 2022 | $1.41 B(-7.1%) | $2.39 B(-2.7%) |
| Sept 2022 | - | $2.45 B(-1.4%) |
| June 2022 | - | $2.49 B(-0.5%) |
| Mar 2022 | - | $2.50 B(+3.3%) |
| Dec 2021 | $1.52 B | $2.42 B(+0.6%) |
| Sept 2021 | - | $2.40 B(-2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $2.46 B(+2.5%) |
| Mar 2021 | - | $2.40 B(-2.2%) |
| Dec 2020 | $1.55 B(+28.2%) | $2.45 B(-1.6%) |
| Sept 2020 | - | $2.49 B(-3.2%) |
| June 2020 | - | $2.58 B(-1.6%) |
| Mar 2020 | - | $2.62 B(+6.6%) |
| Dec 2019 | $1.21 B(-5.9%) | $2.46 B(-1.7%) |
| Sept 2019 | - | $2.50 B(-18.8%) |
| June 2019 | - | $3.08 B(-1.3%) |
| Mar 2019 | - | $3.12 B(+1.6%) |
| Dec 2018 | $1.29 B(+66.7%) | $3.07 B(-2.7%) |
| Sept 2018 | - | $3.15 B(-1.4%) |
| June 2018 | - | $3.20 B(+460.9%) |
| Dec 2017 | $771.93 M | $569.96 M |
FAQ
- What is Amneal Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals annual non current assets year-on-year change?
- What is Amneal Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Amneal Pharmaceuticals?
- What is Amneal Pharmaceuticals quarterly non current assets year-on-year change?
What is Amneal Pharmaceuticals annual long term assets?
The current annual non current assets of AMRX is $2.09 B
What is the all time high annual non current assets for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high annual long term assets is $3.07 B
What is Amneal Pharmaceuticals annual non current assets year-on-year change?
Over the past year, AMRX annual long term assets has changed by -$292.82 M (-12.26%)
What is Amneal Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of AMRX is $1.95 B
What is the all time high quarterly non current assets for Amneal Pharmaceuticals?
Amneal Pharmaceuticals all-time high quarterly long term assets is $3.20 B
What is Amneal Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, AMRX quarterly long term assets has changed by -$283.32 M (-12.70%)